Instil Bio, Inc. (TIL) EBITDA
- 2026-06-30: Basis Reported; EBITDA -$5.33M*; Operating income -$5.58M; Depreciation and amortization $248.00K*.
- 2026-03-31: Basis Reported; EBITDA -$7M; Operating income (m); Depreciation and amortization (m).
- 2025-12-31: Basis Reported; EBITDA -$9.55M; Operating income (m); Depreciation and amortization (m).
- 2025-09-30: Basis Reported; EBITDA -$15.01M*; Operating income -$15.02M; Depreciation and amortization $12.00K*.
Complete source-backed ebitda history.
- Available history
- 2020-03-31 to 2026-03-31
- Data captured
Historical EBITDA
EBITDA 3 month
| Date | Basis | EBITDA | Operating income | Depreciation and amortization | Revenue | EBITDA margin | Capital spending | Operating cash flow | Cost of products and services | Research and development | Selling, general and administration | Income tax expense / benefit |
|---|
| 2026-06-30 | Reported | -$5.33M* | -$5.58M | $248.00K* | (m) | (m) | (m) | -$4.64M* | (m) | (m) | (m) | (m) |
|---|
| 2026-03-31 | Reported | -$7M | (m) | (m) | (m) | (m) | (m) | -$1.34M | (m) | (m) | (m) | (m) |
|---|
| 2025-12-31 | Reported | -$9.55M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2025-09-30 | Reported | -$15.01M* | -$15.02M | $12.00K* | (m) | (m) | (m) | -$10.56M* | (m) | (m) | (m) | (m) |
|---|
| 2025-06-30 | Reported | -$23.43M* | -$23.44M | $12.00K* | (m) | (m) | (m) | -$14.79M* | (m) | (m) | (m) | (m) |
|---|
| 2025-03-31 | Reported | -$30.06M | (m) | (m) | (m) | (m) | (m) | -$4.20M | (m) | (m) | (m) | (m) |
|---|
| 2024-12-31 | Reported | -$11.08M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2024-09-30 | Reported | -$22.73M* | -$23.63M | $901.00K* | (m) | (m) | $0.00* | -$20.13M* | (m) | (m) | (m) | (m) |
|---|
| 2024-06-30 | Reported | -$13.16M* | -$14.13M | $975.00K* | (m) | (m) | $0.00* | -$10.61M* | (m) | $2.92M | (m) | (m) |
|---|
| 2024-03-31 | Reported | -$22.96M | (m) | (m) | (m) | (m) | $0.00 | -$14.39M | (m) | $7.26M | (m) | (m) |
|---|
| 2023-12-31 | Reported | -$11.98M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2023-09-30 | Reported | -$65.76M* | -$66.72M | $953.00K* | (m) | (m) | $5.16M* | -$14.43M* | (m) | $8.49M | (m) | $0.00 |
|---|
| 2023-06-30 | Reported | -$20.00M* | -$20.99M | $991.00K* | (m) | (m) | $6.98M* | -$19.56M* | (m) | $8.46M | (m) | $0.00 |
|---|
| 2023-03-31 | Reported | -$56.67M | (m) | (m) | (m) | (m) | $8.47M | -$34.66M | (m) | $20.67M | (m) | $0.00 |
|---|
| 2022-12-31 | Reported | -$54.7M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2022-09-30 | Reported | -$54.71M* | -$56.65M | $1.94M* | (m) | (m) | $25.20M* | -$40.88M* | (m) | $39.66M | (m) | -$371.00K |
|---|
| 2022-06-30 | Reported | -$57.67M* | -$58.72M | $1.05M* | (m) | (m) | $26.14M* | -$47.26M* | (m) | $41.50M | (m) | -$609.00K |
|---|
| 2022-03-31 | Reported | -$53.39M | (m) | (m) | (m) | (m) | $20.23M | -$55.05M | (m) | $39.17M | (m) | -$488.00K |
|---|
| 2021-12-31 | Reported | -$52.86M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2021-09-30 | Reported | -$42.26M* | -$43.02M | $764.00K* | $0.00 | (m) | $21.75M* | -$29.39M* | (m) | $29.06M | (m) | -$658.00K |
|---|
| 2021-06-30 | Reported | -$34.73M* | -$35.38M | $656.00K* | $0.00 | (m) | $8.49M* | -$32.22M* | (m) | $21.19M | (m) | -$159.00K |
|---|
| 2021-03-31 | Reported | -$22.96M | (m) | (m) | (m) | (m) | $9.13M | -$17.73M | (m) | $14.42M | (m) | -$204.00K |
|---|
| 2020-12-31 | Reported | -$17.33M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2020-09-30 | Reported | -$7.64M* | -$7.71M | $67.00K* | $52.00K | -14700.00%* | $4.30M* | -$7.24M* | (m) | $4.91M | (m) | $0.00 |
|---|
| 2020-06-30 | Reported | -$4.56M* | -$4.59M | $34.00K* | $42.00K | -10854.76%* | $275.00K* | -$3.28M* | (m) | $2.24M | (m) | $0.00 |
|---|
| 2020-03-31 | Reported | -$3.86M | (m) | (m) | (m) | -8763.64% | $968.00K | -$2.28M | (m) | $2.01M | (m) | $0.00 |
|---|
EBITDA 12 month
| Date | Basis | EBITDA | Operating income | Depreciation and amortization | Revenue | EBITDA margin | Capital spending | Operating cash flow | Cost of products and services | Research and development | Selling, general and administration | Income tax expense / benefit |
|---|
| 2025-12-31 | Reported | -$78.05M | (m) | (m) | (m) | (m) | (m) | -$36.62M | (m) | (m) | (m) | $0.00 |
|---|
| 2024-12-31 | Reported | -$69.93M | (m) | (m) | (m) | (m) | $0.00 | -$55.70M | (m) | (m) | (m) | (m) |
|---|
| 2023-12-31 | Reported | -$154.41M | (m) | (m) | (m) | (m) | $20.66M | -$82.03M | (m) | $39.60M | (m) | $0.00 |
|---|
| 2022-12-31 | Reported | -$220.47M | (m) | (m) | (m) | (m) | $84.59M | -$180.16M | (m) | $141.06M | (m) | -$2.07M |
|---|
| 2021-12-31 | Reported | -$152.81M | (m) | (m) | (m) | (m) | $57.83M | -$122.14M | (m) | $107.25M | (m) | $39.00K |
|---|
| 2020-12-31 | Reported | -$33.39M | (m) | (m) | (m) | -24194.20% | $50.82M | -$29.62M | (m) | $19.40M | (m) | $151.00K |
|---|